Pay in 4 interest-free payments of $6.00 Learn more
Ships within 48 hours · Estimated delivery Sep 3 - Sep 8
Weight loss medications containing semaglutide as the active ingredient have been shown to create an energy deficit by suppressing appetite
Even though obesity and other metabolic disorders are known to be higher in IBD patients, medications to treat obesity in this population are underutilized
You are not chasing a jolt
By simultaneously activating the glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) receptors, it effectively promotes insulin secretion and reduces glucagon release, leading to better blood sugar regulation and weight loss support
Bone age assessment may be considered if growth concerns arise
US$ 20.17
US$ 25.10
US$ 26.68
US$ 22.13
US$ 21.76
US$ 24.22
US$ 21.65
